Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Krista A Zanetti, Eliza Mette, Padma Maruvada, John Milner, Steven C Moore, Holly L Nicastro, Sharon A Ross, Joshua N Sampson, Mukesh Verma and Joseph Su L
Metabolomics is an approach that employs technologies to measure small molecule metabolites in biological samples, thus providing epidemiologists and other investigators with a means to discover biomarkers of disease risk, diagnosis, and prognosis. To advance the field of metabolomics, the National Institutes of Health (NIH) is investing $65 million through the NIH Common Fund’s Metabolomics Program, which will support comprehensive metabolomics resource cores, training in metabolomics, metabolomics technology development, metabolomics reference standards synthesis, and data sharing and international collaboration. While this infrastructure will be essential, there remain several challenges to broad implementation of metabolomics in population-based studies. To facilitate the use of metabolomics in population-based studies, the NIH-sponsored ‘Think Tank on the Use of Metabolomics in Population-Based Research’ was held to discuss the current opportunities and challenges of the field and identify potential solutions and/or strategies to address challenges. Insights and conclusions gained from the Think Tank are summarized here.